180 related articles for article (PubMed ID: 27671097)
1. The Sex, Age, Medical History, Treatment, Tobacco Use, Race Risk (SAMe TT
Bernaitis N; Ching CK; Chen L; Hon JS; Teo SC; Davey AK; Anoopkumar-Dukie S
J Stroke Cerebrovasc Dis; 2017 Jan; 26(1):64-69. PubMed ID: 27671097
[TBL] [Abstract][Full Text] [Related]
2. Use of the SAMe-TT2R2 Score to Predict Good Anticoagulation Control with Warfarin in Chinese Patients with Atrial Fibrillation: Relationship to Ischemic Stroke Incidence.
Chan PH; Hai JJ; Chan EW; Li WH; Tse HF; Wong IC; Lip GY; Siu CW
PLoS One; 2016; 11(3):e0150674. PubMed ID: 27010633
[TBL] [Abstract][Full Text] [Related]
3. Prediction of unstable anticoagulation with acenocoumarol versus warfarin in atrial fibrillation.
Bryk AH; Plens K; Undas A
Cardiol J; 2017; 24(5):477-483. PubMed ID: 28353307
[TBL] [Abstract][Full Text] [Related]
4. Determinants of Time in Therapeutic Range in Patients Receiving Oral Anticoagulants (A Substudy of IMPACT).
Lip GY; Waldo AL; Ip J; Martin DT; Bersohn MM; Choucair WK; Akar JG; Wathen M; Halperin JL;
Am J Cardiol; 2016 Dec; 118(11):1680-1684. PubMed ID: 27665206
[TBL] [Abstract][Full Text] [Related]
5. Modified application of SAMe-TT2R2 scoring system in Asian patients with atrial fibrillation for the selection of oral anticoagulants.
Jeon SW; Lee N; Lee KH; Ha M; Kim C; Kim YR; Yoon NS; Park HW
Korean J Intern Med; 2024 May; 39(3):458-468. PubMed ID: 38287499
[TBL] [Abstract][Full Text] [Related]
6. Relation of the SAMe-TT2R2 score to quality of anticoagulation control and thromboembolic events in atrial fibrillation patients: Observations from the SPORTIF trials.
Proietti M; Lane DA; Lip GY
Int J Cardiol; 2016 Aug; 216():168-72. PubMed ID: 27156060
[TBL] [Abstract][Full Text] [Related]
7. The SAMe-TT2R2 Score Predicts Poor Anticoagulation Control in AF Patients: A Prospective 'Real-world' Inception Cohort Study.
Roldán V; Cancio S; Gálvez J; Valdés M; Vicente V; Marín F; Lip GY
Am J Med; 2015 Nov; 128(11):1237-43. PubMed ID: 26087049
[TBL] [Abstract][Full Text] [Related]
8. Quality of oral anticoagulation control in Chinese patients with non-valvular atrial fibrillation: a prospective controlled study.
Li Y; Yu J; Kuang Y; Wu C; Yang L; Fang Q; Pei Q; Yang G
Curr Med Res Opin; 2020 Sep; 36(9):1433-1439. PubMed ID: 32677855
[TBL] [Abstract][Full Text] [Related]
9. Clinical Prediction Model for Time in Therapeutic Range While on Warfarin in Newly Diagnosed Atrial Fibrillation.
Williams BA; Evans MA; Honushefsky AM; Berger PB
J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 29025746
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of SAMe-TT
Hwang AY; Carris NW; Dietrich EA; Gums JG; Smith SM
Ann Pharmacother; 2018 Nov; 52(11):1085-1090. PubMed ID: 29857777
[TBL] [Abstract][Full Text] [Related]
11. The SAMe-TT
Bernaitis N; Clark G; Kohja S; Leong S; Anoopkumar-Dukie S
J Clin Med; 2019 Jun; 8(6):. PubMed ID: 31226834
[TBL] [Abstract][Full Text] [Related]
12. SAMe-TT
Kataruka A; Kong X; Haymart B; Kline-Rogers E; Almany S; Kozlowski J; Krol GD; Kaatz S; McNamara MW; Froehlich JB; Barnes GD
Vasc Med; 2017 Jun; 22(3):197-203. PubMed ID: 28145152
[TBL] [Abstract][Full Text] [Related]
13. SAMe-TT2R2 score for prediction of suboptimal time in therapeutic range in a Thai population with atrial fibrillation.
Krittayaphong R; Winijkul A; Pirapatdit A; Chiewvit P; Komoltri C; Boonyapisit W; Arunsiriwattana S; Bunyapipat T; Apiyasawat S; Rattanasumawong K; Yindeengam A;
Singapore Med J; 2020 Dec; 61(12):641-646. PubMed ID: 31680175
[TBL] [Abstract][Full Text] [Related]
14. A prospective validation of the SAME-TT2R 2 score: how to identify atrial fibrillation patients who will have good anticoagulation control on warfarin.
Poli D; Antonucci E; Testa S; Lip GY
Intern Emerg Med; 2014 Jun; 9(4):443-7. PubMed ID: 24652166
[TBL] [Abstract][Full Text] [Related]
15. SAMe-TT2R2 score, time in therapeutic range, and outcomes in anticoagulated patients with atrial fibrillation.
Gallego P; Roldán V; Marin F; Gálvez J; Valdés M; Vicente V; Lip GYH
Am J Med; 2014 Nov; 127(11):1083-1088. PubMed ID: 24858062
[TBL] [Abstract][Full Text] [Related]
16. Usefulness of the SAME-TT2R2 score to predict anticoagulation control on VKA in patients with atrial fibrillation and obstructive sleep apnea.
Szymanski FM; Lip GY; Filipiak KJ; Platek AE; Karpinski G
Int J Cardiol; 2016 Feb; 204():200-5. PubMed ID: 26670173
[TBL] [Abstract][Full Text] [Related]
17. Validation of the SAMe-TT2R2 score in a nationwide population of nonvalvular atrial fibrillation patients on vitamin K antagonists.
Ruiz-Ortiz M; Bertomeu V; Cequier Á; Marín F; Anguita M
Thromb Haemost; 2015 Oct; 114(4):695-701. PubMed ID: 26054407
[TBL] [Abstract][Full Text] [Related]
18. Identifying Warfarin Control With Stroke and Bleed Risk Scores.
Bernaitis N; Ching CK; Badrick T; Anoopkumar-Dukie S
Heart Lung Circ; 2018 Jun; 27(6):756-759. PubMed ID: 29233496
[TBL] [Abstract][Full Text] [Related]
19. Assessment of the mean time in the therapeutic INR range and the SAME-TT2R2 score in patients with atrial fibrillation and cognitive impairment.
Gorzelak-Pabiś P; Zyzak S; Krewko Ł; Broncel M
Pol Arch Med Wewn; 2016 Aug; 126(7-8):494-501. PubMed ID: 27511466
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of SAMe-TT2R2 score and other clinical factors influencing the quality of anticoagulation therapy in non-valvular atrial fibrillation: a nationwide study in Spain.
Lobos-Bejarano JM; Barrios V; Polo-García J; Escobar C; Vargas-Ortega D; Marín-Montañés N; Prieto-Valiente L; Fuentes S; Prieto MA; García-Ortiz L;
Curr Med Res Opin; 2016 Jul; 32(7):1201-7. PubMed ID: 26967541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
